HerbertStuart BlockBarafMDFACP, MACR

PubMed

• 3 citations
  The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
  Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi, Robert Terkeltaub, Nicola Dalbeth, Wesley DeHaan, Rehan Azeem, Peter G Traber, Robert T Ke...> ;Rheumatology. 2024 Apr 2
• Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.
  Alan Kivitz, Alvin F Wells, Juan I Vargas, Herbert S B Baraf, Maureen Rischmueller, Justin Klaff, Nasser Khan, Yihan Li, Kyle Carter, Alan Friedman, Patrick Durez> ;Rheumatology and Therapy. 2023 Aug 1
• 3 citations
  Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.
  John K Botson, Herbert S B Baraf, Robert T Keenan, John Albert, Karim R Masri, Jeff Peterson, Christianne Yung, Brigid Freyne, Mona Amin, Abdul Abdellatif, Nehad Solom...> ;Current Rheumatology Reports. 2022 Jan 1
• 102 citations
  Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
  Bernard Combe, Alan Kivitz, Yoshiya Tanaka, Désirée van der Heijde, J. Abraham Simon, Herbert S B Baraf, Uma Kumar, Franziska Matzkies, Beatrix Bartok, Lei Ye, Ying Gu...> ;Annals of the Rheumatic Diseases. 2021 Jan 27
• 23 citations
  Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.
  Hanna Ellmann, Sara Bayat, Elizabeth G Araujo, Bernhard Manger, Arnd Kleyer, Alexander Cavallaro, Michael Lell, Hannah Schenker, David Simon, Koray Tascilar, Herbert S...> ;Arthritis & Rheumatology. 2020 Jan 1
• 17 citations
  Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase.
  Robert T. Keenan, Herbert S B Baraf, Brian LaMoreaux> ;Rheumatology and Therapy. 2019 Mar 14
• 10 citations
  Update on imaging in gout: contrasting and comparing the role of dual-energy computed tomography to traditional diagnostic and monitoring techniques.
  Sara Bayat, Herbert S B Baraf, Juergen Rech> ;Clinical and Experimental Rheumatology. 2018 Sep 1
• 3 citations
  The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
  Vance J. Bray, Aaron Broadwell, Herbert S. B. Baraf, Shawn Black, Brenna L. Brady, Joseph Tkacz, Lorraine Yarngo, Raphael J. DeHoratius> ;Drugs in R&D. 2018 Sep 1
• 37 citations
  Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.
  Herbert S B Baraf, Robert A. Yood, Faith D Ottery, John S. Sundy, Michael Becker> ;Journal of Clinical Rheumatology. 2014 Dec 1
• 39 citations
  Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
  Nicola Dalbeth, Anthony Doyle, Fiona M McQueen, John S. Sundy, Herbert S B Baraf> ;Arthritis Care & Research. 2014 Jan 1
• 68 citations
  Tophus burden reduction with pegloticase: Results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
  Herbert S B Baraf, Michael Becker, Sergio R. Gutierrez-Urena, Edward L. Treadwell, Janitzia Vázquez-Mellado, Claudia D. Rehrig, Faith D Ottery, John S. Sundy, Robert A...> ;Arthritis Research & Therapy. 2013 Sep 26
• 92 citations
  Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.
  Robert Terkeltaub, H. Ralph Schumacher, John D. Carter, Herbert S B Baraf, Robert Evans, Jian Wang, Shirletta King-Davis, Steven P. Weinstein> ;Arthritis Research & Therapy. 2013 Feb 1
• 9 citations
  Early effects of tocilizumab in the treatment of moderate to severe active rheumatoid arthritis: a one-week sub-study of a randomised controlled trial (Rapid Onset and...
  Yusuf Yazici, Jeffrey R. Curtis, A Ince, Herbert S B Baraf, Denise M Lepley, Jenny Devenport, Arthur Kavanaugh> ;Clinical and Experimental Rheumatology. 2013 Jan 10
• 65 citations
  Long-term safety of pegloticase in chronic gout refractory to conventional treatment
  Michael Becker, Herbert S B Baraf, Robert A. Yood, Aileen Dillon, Janitzia Vázquez-Mellado, Faith D Ottery, Dinesh Khanna, John S. Sundy> ;Annals of the Rheumatic Diseases. 2013 Sep 1
• 118 citations
  Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: th...
  Yusuf Yazici, Jeffrey R. Curtis, A Ince, Herbert S B Baraf, Raymond L Malamet, Lichen L Teng, Arthur Kavanaugh> ;Annals of the Rheumatic Diseases. 2012 Feb 1
• 26 citations
  Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities.
  Herbert S B Baraf, Morris S. Gold, Richard A. Petruschke, Matthew S. Wieman> ;The American Journal of Geriatric Pharmacotherapy. 2012 Feb 1
• 51 citations
  2011 recommendations for the diagnosis and management of gout and hyperuricemia
  Max I. Hamburger, Herbert S B Baraf, Thomas C. Adamson, Jan Basile, Lewis Bass, Brent Cole, Paul P. Doghramji, Germano A. Guadagnoli, Frances Hamburger, Regine Harford...> ;The Physician and Sportsmedicine. 2011 Nov 1
• 74 citations
  2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
  Max I. Hamburger, Herbert S B Baraf, Adamson Tc rd, Jan Basile, Lewis Bass, Cole B, Paul P. Doghramji, Guadagnoli Ga, Hamburger F, Harford R, Lieberman Ja rd, Mandel D...> ;Postgraduate Medicine. 2011 Nov 1
• 355 citations
  Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment: Two Randomized Controlled Trials
  John S. Sundy, Herbert S B Baraf, Robert A. Yood, N. Lawrence Edwards, Sergio R. Gutierrez-Urena, Edward L. Treadwell, Janitzia Vázquez-Mellado, William B. White, Pete...> ;JAMA. 2011 Aug 17
• 43 citations
  Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel...
  Herbert S B Baraf, F. Michael Gloth, H. Richard Barthel, Morris S. Gold, Roy D. Altman> ;Drugs & Aging. 2011 Jan 1
• 38 citations
  Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial.
  Herbert S B Baraf, Morris S. Gold, Michael B Clark, Roy D. Altman> ;The Physician and Sportsmedicine. 2010 Jun 1
• 32 citations
  Resolution of gouty tophi after twelve weeks of pegloticase treatment
  Herbert S B Baraf, Alan K. Matsumoto, Allan N. Maroli, Royce W. Waltrip> ;Arthritis and Rheumatism. 2008 Nov 1
• 119 citations
  Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gou...
  John S. Sundy, Michael Becker, Herbert S B Baraf, André Barkhuizen, Larry W. Moreland, William Huang, Royce W. Waltrip, Allan N. Maroli, Zeb Horowitz, Pegloticase Phas...> ;Arthritis and Rheumatism. 2008 Sep 1
• 54 citations
  A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout
  William J. Taylor, Schumacher Hr, Herbert S B Baraf, Peter T. Chapman, Lisa K. Stamp, Michael Doherty, Fiona M McQueen, Nicola Dalbeth, Naomi Schlesinger, Daniel E. Fu...> ;Annals of the Rheumatic Diseases. 2008 Jun 1
• 16 citations
  Efficacy of the newest COX-2 selective inhibitors in rheumatic disease.
  Herbert S B Baraf> ;Current Pharmaceutical Design. 2007 Jul 31
• Join now to see all